DSE/JMISMDL (DSE/JMISMDL)

Dhaka Stock Exchange: DSE/JMISMDL · BDT

BDT 124

+2.10 (+1.7%)· Recorded snapshot

Market cap	3.7B
Revenue (ttm)	1.7B
Net income (ttm)	-92.6M
EPS (ttm)	-BDT 3.08
Shares out	30.1M
Dividend	BDT 1.00 (0.81%)
Volume	7,215
Beta	0.05

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.7B
Net income (ttm): -92.6M
EPS (ttm): -BDT 3.08
Market cap: 3.7B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-3.6

P25 n/aP50 n/aP75 n/a

ROIC1.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All DSE/JMISMDL indicators

Market & fundamental data

Available fields

219

Groups with data

Currency

BDT

Showing 219 of 219 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BDT
Country	Bangladesh
Country code	BD
Earnings date	2026-11-01
Employees	1,173
Employees change	195
Employees growth	19.94%
Enterprise value	BDT 3.7B
Exchange	Dhaka Stock Exchange
Financial currency	BDT
Financial report date	2026-03-31
First seen	2026-05-10
Fiscal year end	June
Founded	1999
Industry	Surgical and Medical Instruments and Apparatus
Is primary listing	Yes
ISIN number	BD0000JBCL09
Last earnings date	2026-04-28
Last refreshed	2026-10-29
Last stock split date	2022-11-15
Last stock split type	Forward
Market cap	BDT 3.7B
Next earnings date	2026-11-01
Price	BDT 124.20
Price currency	BDT
SIC code	3841
Stock price date	2026-10-28
Symbol	dse/JMISMDL
Website	https://www.jmisyringe.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	77.84x
Average P/E ratio (5Y)	122.33x
Earnings yield	-2.48%
EV/EBIT	137.21x
EV/EBITDA	39.55x
EV/FCF	46.56x
EV/Sales	2.18x
FCF / EV yield	2.15%
FCF yield	2.1%
P/B ratio	1.49x
P/FCF ratio	47.58x
P/OCF ratio	41.84x
P/S ratio	2.23x
Price / tangible book value	1.49x
Price/EBITDA ratio	40.72x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	1.59%
EBITDA margin	5.48%
FCF margin	4.69%
Gross margin	11.04%
Operating margin	1.59%
Pretax margin	-3.01%
Profit margin	-5.53%
Profit per employee	BDT -78,984
Revenue per employee	BDT 1.4M
ROA	0.55%
ROA (5Y)	2.93%
ROCE	1.02%
ROE	-3.61%
ROE (5Y)	0.92%
ROIC	1.07%
ROIC (5Y)	0.84%
Tax / revenue	2.52%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
FCF growth	-13.78%
FCF growth (QoQ)	74.57%
FCF growth 3Y	119.52%
FCF growth 5Y	-1.07%
Gross profit growth	-44.43%
Gross profit growth (Q)	-22.93%
Gross profit growth 3Y	-14.21%
Gross profit growth 5Y	-11.93%
OCF growth	-11.44%
OCF growth (QoQ)	75.7%
OCF growth 10Y	-8.31%
OCF growth 3Y	14.5%
OCF growth 5Y	-14.78%
Operating income growth	-84.62%
Operating income growth (Q)	-71.32%
Operating income growth 3Y	-43.09%
Operating income growth 5Y	-32.27%
Revenue growth	-12.91%
Revenue growth (Q)	-6.4%
Revenue growth (QoQ)	-5.46%
Revenue growth 10Y	2.87%
Revenue growth 3Y	-8.54%
Revenue growth 5Y	-3.79%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BDT -10.8M
Depreciation and amortization	BDT 65.1M
EBIT	BDT 26.6M
EBITDA	BDT 91.7M
EPS	BDT -3.08
FCF per share	BDT 2.61
Financing cash flow	BDT -70.4M
Free cash flow	BDT 78.5M
Gross profit	BDT 184.8M
Income taxes	BDT 42.3M
Investing cash flow	BDT -10.8M
Net borrowing	BDT -37.5M
Net cash flow	BDT 8.1M
Net income	BDT -92.6M
Operating income	BDT 26.6M
Revenue	BDT 1.7B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	5.89
Book value per share	BDT 83.34
Debt / EBITDA	0.28
Debt / equity	0.01
Debt / FCF	0.32
Interest coverage	235.54
Long-term assets	BDT 1.3B
Long-term liabilities	BDT 108.6M
Net cash (debt)	BDT 79.9M
Net cash / market cap	2.14%
Net cash growth	135.14%
Net debt / EBITDA	-0.87
Net debt / equity	-0.03
Net debt / FCF	-1.02
Piotroski F-Score	3
Property, plant and equipment	BDT 1.3B
Shareholders' equity	BDT 2.5B
Tangible book value	BDT 2.5B
Tangible book value per share	BDT 83.28
Total assets	BDT 3B
Total cash	BDT 105.4M
Total debt	BDT 25.5M
Total liabilities	BDT 504.4M
WACC	4.51%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.55
Current assets	BDT 1.7B
Current liabilities	BDT 395.9M
Current ratio	4.34
Inventory turnover	2.4
Net working capital	BDT 1.2B
Quick ratio	1.83
Working capital	BDT 1.3B
Working capital turnover	1.24

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend growth	0%
Dividend growth (10Y)	-9.02%
Dividend growth (3Y)	0%
Dividend growth (5Y)	-14.63%
Dividend growth years	0
Dividend payment date	2027-01-24
Dividend payment years	4
Dividend payout frequency	Annual
Dividend per share	BDT 1.00
Dividend yield	0.81%
Ex-dividend date	2026-11-24
FCF payout ratio	38.31%
Last dividend	BDT 1.00
Shareholder yield	0.81%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-11.38%
10Y return CAGR	-0.36%
10Y total return	-3.58%
150-day SMA	BDT 131.87
1D price change	1.72%
1M price change	-3.94%
1M total return	-3.94%
1W price change	7.16%
1W total return	7.16%
1Y price change	-4.46%
1Y return CAGR	-3.59%
1Y total return	-3.59%
20-day SMA	BDT 125.33
200-day SMA	BDT 129.11
3M price change	-12.35%
3M total return	-12.35%
3Y price change	-51.39%
3Y return CAGR	-20.84%
3Y total return	-50.41%
50-day SMA	BDT 130.32
50-day SMA vs 200-day SMA	50over200
52-week high	BDT 163.40
52-week high date	2026-07-08
52-week low	BDT 105.90
52-week low date	2025-11-16
5Y price change	-51.52%
5Y return CAGR	-12.98%
5Y total return	-50.11%
6M price change	-4.75%
6M total return	-4.75%
All-time high	BDT 404.04
All-time high date	2022-10-19
All-time low	BDT 26.10
All-time low date	2013-06-19
Average true range (ATR)	BDT 4.63
Average volume	9.1K
Beta (1Y)	0.27
Beta (2Y)	-0.03
Beta (5Y)	0.05
Change from 52-week high	-23.99%
Change from 52-week low	17.28%
Change from all-time high	-69.26%
Change from all-time low	375.81%
Change from open	2.64%
Day's gap	-0.9%
Dollar volume	BDT 896,103
High price	BDT 125.00
Low price	BDT 120.20
Monthly RSI	42.29
Open price	BDT 121.00
Position in 52-week range	83.33%
Previous close	BDT 122.10
Price vs 150-day SMA	-5.82%
Price vs 20-day SMA	-0.9%
Price vs 200-day SMA	-3.8%
Price vs 50-day SMA	-4.69%
Relative volume	0.79
RSI	46.08
Sharpe ratio	-0.27
Sharpe ratio (3Y)	-0.55
Sharpe ratio (5Y)	-0.28
Sortino ratio	-0.24
Sortino ratio (3Y)	-0.68
Sortino ratio (5Y)	-0.27
Volume	7.2K
Weekly RSI	0
YTD price change	4.55%
YTD total return	4.55%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6.1M
Shares change (QoQ)	-0.11%
Shares held by insiders	29.42%
Shares outstanding	30.1M

Deeper analysis on DSE/JMISMDL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this DSE/JMISMDL report

Is a complete DSE/JMISMDL research report available?

No complete published report is available for dse/JMISMDL (DSE/JMISMDL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

DSE/JMISMDL (DSE/JMISMDL)

Price

Financial snapshot

Fair-value bridge

Latest news · DSE/JMISMDL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All DSE/JMISMDL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on DSE/JMISMDL

Frequently asked questions